Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
4-Piperidinecarboxamide → 1-(4-{3-[6-(4-Isopropylpiperazin-1-yl)pyridin-3-yl][1,2,4]oxadiazol-5-yl}benzyl)piperidine-4-carboxylic acid amide, dihydrochloride
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | 4-Piperidinecarboxamide | HCID 3772 | — |
| 반응물 | 1-(5-(5-(4-Chloromethylphenyl)[1,2,4]oxadiazol-3-yl)pyridine-2-yl)-4-isopropylpiperazine | HCID 15951386 | — |
| 생성물 | 1-(4-{3-[6-(4-Isopropylpiperazin-1-yl)pyridin-3-yl][1,2,4]oxadiazol-5-yl}benzyl)piperidine-4-carboxylic acid amide, dihydrochloride | HCID 131730774 | — |
반응 단계
The title compound was prepared by a similar procedure to that described in Example 44, starting from 1-(5-(5-(4-chloromethylphenyl)[1,2,4]oxadiazol-3-yl)pyridine-2-yl)-4-isopropylpiperazine and isonipecotamide.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US08846677B2 |
| 출처 데이터셋 | uspto-grants-2014_09 |
| ORD ID | ord-2a0917b1d8fb48c4b6287bcee683bb9b |
| 출처 메모 | uspto-grants-2014_09 |